Clinical trial
Evaluation of the Effects of Duloxetine on Norepinephrine Transporter Inhibition in Healthy Subjects
NCT00414323 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effects of Duloxetine on Norepinephrine Transporter Inhibition in Healthy Subjects
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- May 31, 2007
- Enrollment
- 35 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.